U.S. Physical Therapy (NYSE:USPH) Shares Pass Above 200 Day Moving Average of $95.00

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $95.00 and traded as high as $98.38. U.S. Physical Therapy shares last traded at $97.60, with a volume of 60,739 shares trading hands.

Analyst Ratings Changes

USPH has been the topic of a number of analyst reports. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. Barrington Research boosted their price target on U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Finally, JPMorgan Chase & Co. boosted their price target on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a report on Wednesday, March 13th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $125.67.

U.S. Physical Therapy Stock Up 1.6 %

The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28. The firm has a market capitalization of $1.49 billion, a PE ratio of 73.40, a PEG ratio of 4.62 and a beta of 1.39. The company has a fifty day simple moving average of $104.57 and a two-hundred day simple moving average of $95.05.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 28th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.02. The company had revenue of $154.80 million during the quarter, compared to analysts’ expectations of $150.24 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The firm’s revenue was up 9.6% compared to the same quarter last year. During the same period last year, the business posted $0.58 earnings per share. Analysts forecast that U.S. Physical Therapy, Inc. will post 2.77 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, March 12th were issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 1.78%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.43. The ex-dividend date was Monday, March 11th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 130.37%.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Clayton Trier sold 400 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $107.00, for a total value of $42,800.00. Following the sale, the director now directly owns 7,000 shares of the company’s stock, valued at $749,000. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, Director Edward L. Kuntz sold 2,500 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $104.26, for a total transaction of $260,650.00. Following the transaction, the director now owns 5,780 shares in the company, valued at $602,622.80. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Clayton Trier sold 400 shares of U.S. Physical Therapy stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $107.00, for a total value of $42,800.00. Following the completion of the sale, the director now owns 7,000 shares in the company, valued at approximately $749,000. The disclosure for this sale can be found here. Insiders have sold a total of 10,829 shares of company stock valued at $1,141,535 over the last ninety days. Company insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Institutional investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in U.S. Physical Therapy by 1.7% during the 3rd quarter. Vanguard Group Inc. now owns 1,036,203 shares of the company’s stock worth $95,051,000 after buying an additional 17,156 shares during the last quarter. Schroder Investment Management Group raised its stake in U.S. Physical Therapy by 12.1% during the 3rd quarter. Schroder Investment Management Group now owns 384,936 shares of the company’s stock valued at $35,310,000 after acquiring an additional 41,414 shares during the last quarter. Copeland Capital Management LLC raised its stake in U.S. Physical Therapy by 6.8% during the 3rd quarter. Copeland Capital Management LLC now owns 770,613 shares of the company’s stock valued at $70,688,000 after acquiring an additional 49,155 shares during the last quarter. First Dallas Securities Inc. purchased a new stake in U.S. Physical Therapy during the 3rd quarter valued at approximately $1,073,000. Finally, Deutsche Bank AG raised its stake in U.S. Physical Therapy by 20.0% during the 3rd quarter. Deutsche Bank AG now owns 7,509 shares of the company’s stock valued at $689,000 after acquiring an additional 1,252 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.